Recruiting OBSERVATIONAL NCT07047573

Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules

Clinical Application Research on Differentiating Benign and Malignant Pulmonary Nodules Based on Multi-omics Detection Technology

Sponsor: Zhao Jun

Conditions Lung Cancer (Diagnosis) Pulmonary Nodule Persistent

Interventions PBMCS were isolated from the peripheral blood of hospitalized patients with pulmonary nodules and incubated with nanoparticles loaded with tumor antigens for a specific period of time to detect cancer

Updated 1 time since 2025 Last updated: Jun 24, 2025 Started: Jun 1, 2025 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Lung Cancer (Diagnosis) and Pulmonary Nodule Persistent and is currently actively recruiting participants. Zhao Jun leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

1 version recorded

Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhao Jun

Data source: The First Affiliated Hospital of Soochow University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suzhou, China